#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA668916	B	In vitro inhibition against hog kidney diamine oxidase	Sus scrofa	1	ALA1124320	single protein format	Scientific Literature
2.	ALA668917	B	Tested for ability to competitively inhibit hog kidney diamine oxidase (DAO) in a spectrometric assay	Sus scrofa	5	ALA1127192	single protein format	Scientific Literature
3.	ALA668918	B	Inhibitory activity against Swine kidney diamine oxidase (SKDAO)	Sus scrofa	4	ALA1135016	single protein format	Scientific Literature
4.	ALA668919	B	Inhibitory activity against Swine kidney diamine oxidase (SKDAO); No inhibition, corresponding to value >10e-4	Sus scrofa	2	ALA1135016	single protein format	Scientific Literature
5.	ALA827081	B	Km for Diamine oxidase of porcine kidney	Sus scrofa	2	ALA1141879	single protein format	Scientific Literature
6.	ALA828103	B	Inhibition of putrescine binding to Diamine oxidase of porcine kidney	Sus scrofa	1	ALA1141879	single protein format	Scientific Literature
7.	ALA828122	B	Inhibition of putrescine binding to against Diamine oxidase of porcine kidney	Sus scrofa	21	ALA1141879	single protein format	Scientific Literature
8.	ALA828620	B	Vmax for Diamine oxidase of porcine kidney	Sus scrofa	2	ALA1141879	single protein format	Scientific Literature
9.	ALA874951	F	Inhibition of putrescine binding to Diamine oxidase of porcine kidney	Sus scrofa	1	ALA1141879	assay format	Scientific Literature
10.	ALA3242684	B	Mixed type inhibition of recombinant human DAO expressed in drosophila S2 cells	Homo sapiens	2	ALA3232957	cell-based format	Scientific Literature
11.	ALA3888274	B	DAO Inhibition Assay: Recombinant human DAO (2.4 μg/mL) was used as source of DAO enzyme activities. The assay was performed as described in the method for human SSAO/VAP-1 (Example 5) except the substrate used was 200 μM putrescine, and the control wells contained 10 μM aminoguanidine instead of Mofegiline: Briefly, in a standard 96 well plate assay 50 μL of purified human SSAO/VAP-1 (0.25 μg/mL) in 0.1 M NaPO4 buffer (pH 7.4) was added into each well. Test compounds were dissolved in DMSO and tested in a Concentration Response Curve (CRC) with 4-9 data points, typically in the micromolar or nanomolar range after incubation with human SSAO/VAP-1 for 30 min at 37 °C. After 30 min incubation, 50 μL of the reaction mixture containing 600 μM benzylamine (Sigma Aldrich), 120 μM Amplex Red (Sigma Aldrich) and 1.5 U/mL horseradish peroxidase (Sigma Aldrich) prepared in 0.1 M NaPO4 buffer (pH 7.4) were added to the corresponding well. The fluorescence unit (RFU) was read every 2.5 min for 30 min at 37 °C. excitation 565 nm and emission 590 (Optima; BMG labtech). The slope of the kinetics for each well was calculated using MARS data analysis software (BMG labtech) and this value was used to deduce the IC50 value (Dotmatics).		24	ALA3886634	single protein format	BindingDB Database
12.	ALA4052339	B	Inhibition of recombinant human DAO assessed as reduction of H2O2 production from oxidative deamination of DAP at 10 uM preincubated for 2 hrs followed by substrate addition measured every 2 mins for 1 hr by amplex red reagent-based fluorescence assay	Homo sapiens	3	ALA4049456	single protein format	Scientific Literature